Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prockop, L. D.
Right arrow Articles by Shug, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prockop, L. D.
Right arrow Articles by Shug, A. L.
NEUROLOGY 1983;33:1629
© 1983 American Academy of Neurology

Nearly fatal muscle carnitine deficiency with full recovery after replacement therapy

Leon D. Prockop, W. King Engel and Austin L. Shug

College of Medicine (Dr. Prockop), University of South Florida, Tampa, FL, the National Institutes of Health (Dr. Engel), Bethesda, MD, and the School of Medicine, University of Wisconsin and Madison VA Hospital (Dr. Shug), Madison, WI.

A 23-year-old woman became quadriplegic and respirator-dependent after 18 years of weakness and rhabdomyolysis. Her muscle tissue and that of a deceased sister contained lipid-laden fibers. Treatment with D, L-carnitine 4 grams per day was followed by a dramatic improvement within 10 days. Muscle function was normal at 8 months and has remained so during 3 subsequent years of L-carnitine 3 grams per day. Pretreatment muscle biopsy had documented low levels of free carnitine and short-chain acylcarnitine compounds. Carnitine palmityltransferase was slightly elevated. The asymptomatic parents had low-normal muscle carnitine levels, slight increase in muscle fiber lipid droplets, osmiophilic lipid-laden Schwann's cell vacuoles, and myelin lamellae with different periodicities.

Address correspondence and reprint requests to Dr. Prockop, Box 55, 12901 N. 30th Street, Tampa, FL 33612.

Accepted for publication April 13, 1983.




This article has been cited by other articles:


Home page
J Child NeurolHome page
R. Pons and D. C. De Vivo
Primary and Secondary Carnitine Deficiency Syndromes
J Child Neurol, November 1, 1995; 10(2_suppl): 2S8 - 2S24.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by AAN Enterprises, Inc.